Baker Avenue Asset Management’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
– Sell
-387
Closed -$61.5K – 1236
2023
Q3
$61.5K Sell
387
-19
-5% -$3.11K ﹤0.01% 494
2023
Q2
$57.4K Hold
406
– – ﹤0.01% 509
2023
Q1
$68.4K Sell
406
-2
-0.5% -$357 ﹤0.01% 487
2022
Q4
$69.1K Buy
+408
New +$74K ﹤0.01% 450

Other funds holding RGEN

Baker Avenue Asset Management's RGEN Position: Q4 2023 in Review

Baker Avenue Asset Management sold out of Repligen (RGEN) in Q4 2023, closing a stake of 387 shares — an estimated $61.5K sold.

Baker Avenue Asset Management first reported a position in RGEN in Q4 2022 and held it in 4 quarters. The position peaked at $69.1K in Q4 2022. 466 funds tracked by Wall St. Rank hold RGEN as of Q4 2023.

  • Baker Avenue Asset Management reported no remaining Repligen position as of Q4 2023 after selling out during the quarter.
  • Baker Avenue Asset Management sold 387 Repligen shares in Q4 2023, an estimated $61.5K.
  • Baker Avenue Asset Management first reported a position in Repligen in Q4 2022 and held it in 4 quarters.
  • Baker Avenue Asset Management's Repligen position peaked at $69.1K in Q4 2022.
  • 466 funds tracked by Wall St. Rank held Repligen as of Q4 2023.

Based on Baker Avenue Asset Management's 13F filing for Q4 2023, filed 13 Feb 2024.